HYDROXYZINE VIATRIS 25 mg, film-coated tablet scored 250 tablets
Active ingredients: Hydroxyzine monohydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored250 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- HYDROXYZINE VIATRIS 25 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) de 250 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Mar 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescription valid for up to 12 weeks
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69638464CIP75502902CIP133400955029021Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'HYDROXYZINEcomprimé | 25 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.